{"schema_version":"1","generated_at":"2026-11-20T11:05:23.390Z","data_as_of":null,"url":"https://www.findmykol.com/kol/karl-insogna","json_url":"https://www.findmykol.com/kol/karl-insogna/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"karl-insogna","name":"Karl Insogna","credential":"MD","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"Yale University","institution_url":"https://www.findmykol.com/institution/yale-school-of-medicine","city":"New Haven","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Karl Insogna is an Endocrinology/Metabolic physician affiliated with Yale University. OpenAlex indexes 320 publications with 22,322 citations (h-index 78); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":320,"cited_by_count":22322,"h_index":78,"latest_activity_year":2025,"citation_standing":{"top_percent":5,"cohort":"Endocrinology, Diabetes & Metabolism","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04146935","title":"Examining the Effect of Burosumab on Muscle Function","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT04146935","trial_url":"https://www.findmykol.com/trial/NCT04146935"},{"nct":"NCT01652573","title":"Calcitonin for Treating X-linked Hypophosphatemia","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT01652573","trial_url":"https://www.findmykol.com/trial/NCT01652573"},{"nct":"NCT00719160","title":"The Effect of Protein on Calcium Absorption and Gastric Acid Production","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT00719160","trial_url":"https://www.findmykol.com/trial/NCT00719160"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"KYOWA KIRIN, INC.","program_year":2025,"amount_usd":12065.53,"payment_count":12},{"payer":"Kyowa Kirin, Inc.","program_year":2024,"amount_usd":12581.12,"payment_count":16},{"payer":"Kyowa Kirin Services Ltd","program_year":2024,"amount_usd":2392.5,"payment_count":2}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Hormonal (systemic)","share_pct":100,"classes_total":1,"classes":[{"class":"Parathyroid Hormone Analog","setting":"prescribed","share_pct":100,"drugs":[{"name":"Forteo","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":17,"fiscal_years":{"first":1989,"last":2025},"rows_total":125,"shown":3,"withheld":122,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01AR081074","title":"Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass","fiscal_year":2025,"amount_usd":"639521","organization":"YALE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01AR081074"},{"project":"R01AR081074","title":"Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass","fiscal_year":2024,"amount_usd":"639520","organization":"YALE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01AR081074"},{"project":"R01AR081074","title":"Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass","fiscal_year":2023,"amount_usd":"659298","organization":"YALE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01AR081074"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"The clinician’s guide to prevention and treatment of osteoporosis","year":2022,"journal":"Osteoporosis International","source_url":"https://doi.org/10.1007/s00198-021-05900-y","status":"verified"},{"title":"Update on Osteoporosis Screening and Management","year":2021,"journal":"Medical Clinics of North America","source_url":"https://doi.org/10.1016/j.mcna.2021.05.016","status":"verified"},{"title":"Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism","year":2020,"journal":"Journal of Bone and Mineral Research","source_url":"https://doi.org/10.1002/jbmr.4665","status":"verified"},{"title":"Burosumab for the Treatment of Tumor-Induced Osteomalacia","year":2020,"journal":"Journal of Bone and Mineral Research","source_url":"https://doi.org/10.1002/jbmr.4233","status":"verified"},{"title":"Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period","year":2019,"journal":"Calcified Tissue International","source_url":"https://doi.org/10.1007/s00223-019-00568-3","status":"verified"}],"source":"works"},"similar":[{"name":"John Krystal","slug":"john-krystal","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/john-krystal","json_url":"https://www.findmykol.com/kol/john-krystal/profile.json"},{"name":"Lajos Pusztai","slug":"lajos-pusztai","institution":"Yale University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/lajos-pusztai","json_url":"https://www.findmykol.com/kol/lajos-pusztai/profile.json"},{"name":"Lee Schwamm","slug":"lee-schwamm","institution":"Yale University","specialty":"Neurology","url":"https://www.findmykol.com/kol/lee-schwamm","json_url":"https://www.findmykol.com/kol/lee-schwamm/profile.json"},{"name":"Thomas McGlashan","slug":"thomas-mcglashan","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/thomas-mcglashan","json_url":"https://www.findmykol.com/kol/thomas-mcglashan/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":5,"funding":122,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}